OPTIBIOTIX HEALTH PLC (OPTI) — Commercial update

Investor webinar replay

Replay transcript excerpt

Good afternoon, and welcome to the OPTIBIOTIX HEALTH PLC investor presentation. Throughout this recorded presentation, investors will be in listen only mode. Questions are encouraged, and they can be submitted at any time using the Q and A tab situated on the right hand corner of your screen. Simply tap in your questions and present. The company may not be in a position to answer every question or receives during the meeting itself. However, company can review all questions submitted today and publish responses where it's appropriate to do so. Before we begin, I would like to submit the following poll, and I would now like to hand you over to CEO, Steven O'Hara. Good afternoon to you. Hi. Good afternoon, Alex, and thanks very much for the introduction. So my name is Steven Juara, as Alex said. I'm the founder and CEO of OPTIBIOTIX HEALTH PLC. And today, I'm just gonna give you a commercial update. I'm really looking forward to 2024 and trying to set the scene. We had a difficult 2022. We can recover very much in 2023. We got a lot of good stories to tell for 2024, a change in environment in terms of the changes in terms of the anti obesity drugs, the strategy we set out to expand into into Asia and into The USA, bringing on some really big big partners, and also our strategy to go more down the ecommerce route, and I'll try to explain the reasons why. And then finally, I'll talk about the second generation products. That'll be fairly brief. So I wanna do a separate presentation on that. At this moment in time, we've got a lot of really good commercial discussions taking place. You know, we have some big partners with The US company and also DSM, and I have to be very careful in terms of the sensitivities because I don't wanna get to situations sometime we did with Ta...